Navigation Links
HealthLink Europe's U.S. Operation Supports First FDA IDE Trial
Date:11/11/2013

RALEIGH, N.C. and 'S-HERTOGENBOSCH, Netherlands, Nov. 11, 2013 /PRNewswire/ -- HealthLink Europe, an ISO 13485:2012 certified company specializing in providing front and back office support, VAT deferment, fulfillment and logistics services to medical device companies since 1994, is now supporting a European-based client's FDA IDE Trial in the United States for a Class III device in the interventional cardiology space.

HealthLink Europe has had a Business Development and Client Relations office based in Raleigh, North Carolina since 2004, but they have now expanded their North American capabilities to include logistical support. HealthLink's expansion of operational services to the U.S. offers its current clients the advantage of working with the same platform for their sites in the U.S. as they do for their European operations.

HealthLink plans to grow its North American warehousing and logistics services with the expansion of its U.S. team based in Raleigh, North Carolina. Sebastiaan "Bas" de Kok, Operations Manager at HealthLink Europe, will join the U.S.A. team this year, bringing with him the knowledge and experience necessary to further develop HealthLink's North American endeavor.

"It is our plan to have a North American operation that offers similar services to our current European facility in the Netherlands," explains Rick Hughes, president of HealthLink Europe. "We're very excited about our expansion and we're looking forward to supporting our clients as they expand into other markets."

ABOUT HEALTHLINK EUROPE:
HealthLink Europe is 100% medical, ISO 13485 certified, specializing in class II and III devices and their associated regulatory requirements.

Acting as an extension of its customers' business, HealthLink provides Customer Care Services, Financial Services, Warehousing and Logistics, Fulfillment and Value Added Services, IT Support, Authorized Representative services, and more.

For more information, visit www.healthlinkeurope.com, or call Toll Free:(800) 781-8926.

For media inquiries, please contact:
Savanna Bohlman Fann
Communications Manager, HealthLink Europe
(800) 781-8926


'/>"/>
SOURCE HealthLink Europe
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
2. PharmAthene Reports Third Quarter 2013 Financial And Operational Results
3. Intersurgical, ERDRICH Umformtechnik und Bridgestone gehen Kooperation mit dem Changzhou National Hi-Tech District ein
4. Celtaxsys Restructures, Enhances Operational Focus
5. Neue Studie kommt zu dem Schluss, dass manche Patienten mit Refluxkrankheit von Stretta eher profitieren als von chronischer Behandlung mit Protonenpumpenhemmern oder Antireflux-Operation
6. GenVec Board Restructures Operations and Withdraws Plan of Dissolution
7. X-Change Corp. Delighted with DOJs Historic Shift Toward Non-Interference Within State Cannabis Regulatory Environments; Sees Green Light for Companys Patient-Driven Medical Cannabis Operations Under State Laws
8. PA Governor Corbett: Americure Rx Establishes Operations in Lehigh Valley; Creates 51 Jobs
9. PendoTECH Launches New In-line Single Use Conductivity Sensors for Critical Bioprocess Operations
10. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
11. Ambit Biosciences to Announce Second Quarter 2013 Operational Results and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
Breaking Medicine News(10 mins):